Incyte | INCY - Ebitda





Ebitda Veränderung Datum
Acadia Pharmaceuticals USD 40.99M 42.62M 2026-06
Agenus USD -10.11M 19.02M 2025-03
Agios Pharmaceuticals USD -109.2M 540K 2026-06
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
Amgen USD 5.8B 1.25B 2026-09
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Biogen USD 450.8M 198.9M 2026-06
BioMarin Pharmaceutical USD 222.32M 76.27M 2026-06
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Eli Lilly USD 9.46B 3.54B 2026-09
Exelixis USD 275.36M 19.96M 2026-09
Gilead Sciences USD -9.31B 12.82B 2026-06
Incyte USD 778.57M 410.6M 2026-06
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
MacroGenics USD -64.54M 34.34M 2026-06
Merck USD 1.42B 2.97B 2026-06
Moderna USD -687M 571M 2026-06
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Neurocrine Biosciences USD 375.3M 185.4M 2026-09
Novartis USD 8.62B 2.14B 2026-09
Novartis USD 5.36B 45M 2026-09
Pfizer USD 6.36B 350M 2026-09
PTC Therapeutics USD 161.9M 99.92M 2026-06
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Sarepta Therapeutics USD -3.14M 33.31M 2026-09
Ultragenyx Pharmaceutical USD -61M 94M 2026-06
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06